📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split
15%
• 52-week low $0.96 has breached $1
💹 Market Data
Market Cap$249.97M
Shares Outstanding90.90M
Float72.98M
Cash$65.14M
Debt$72.90M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.7% shares (2025Q4 vs prior)
126 institutional holders · 65.54M shares
#1
Aberdeen Group plc
7.97M shares
#2
BlackRock, Inc.
7.40M shares
#3
Opaleye Management Inc.
6.79M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest4.68M
Days to Cover3.7
% of Float6.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2010
4
INSIDER TRANSACTION
Feb 25, 2026
4
INSIDER TRANSACTION
Feb 25, 2026
4
INSIDER TRANSACTION
Feb 25, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CDXS
📊 CDXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CDXS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.